{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:52:54Z","timestamp":1791006774707,"version":"4.1.0"},"reference-count":75,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2026,10,1]]},"DOI":"10.5551\/jat.rv22056","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T22:11:09Z","timestamp":1784758269000},"page":"1232-1245","source":"Crossref","is-referenced-by-count":0,"title":["The PREVENT Risk Equations and Cardiovascular Prevention in East Asia"],"prefix":"10.5551","volume":"33","author":[{"given":"Mitsuaki","family":"Sawano","sequence":"first","affiliation":[{"name":"Teikyo Academic Research Center, Teikyo University"},{"name":"Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine"},{"name":"Center for Outcomes Research and Evaluation, Yale New Haven Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ejiri","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichiro","family":"Mori","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Behavioral Sciences, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hokyou","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine"},{"name":"Yonsei Institute for Digital Health, Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Health Promotion and Behavioral Sciences, Graduate School of Medicine, Kyoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Keio University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon Chang","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Yonsei University College of Medicine"},{"name":"Yonsei Institute for Digital Health, Yonsei University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Nguyen PK, Zhao D, Okamura T, Kim HC, Wong ND, Yang E. Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea: Implications for East Asians?. JACC Asia, 2025; 5: 333-349","DOI":"10.1016\/j.jacasi.2025.01.006"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Zhang Y, Deng Q, Hu P, Zeng Q, Li B, Liu J. Burden and Risk Factors of Cardiovascular Diseases in Asia, 1990-2021: An Analysis for GBD 2021. JACC Asia, 2025; S2772-3747(25)00518-6 [in press]","DOI":"10.1016\/j.jacasi.2025.08.024"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular Disease and Risk Factors in Asia: A Selected Review. Circulation, 2008; 118: 2702-2709","DOI":"10.1161\/CIRCULATIONAHA.108.790048"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Global Burden of Cardiovascular Diseases and Risks 2023 Collaborators. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. J Am Coll Cardiol, 2025; 86: 2167-2243","DOI":"10.1016\/j.jacc.2025.08.015"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) D\u2019Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study. Circulation, 2008; 117: 743-753","DOI":"10.1161\/CIRCULATIONAHA.107.699579"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D\u2019Agostino RB, Gibbons R, Greenland P, Lackland DT, Levy D, O\u2019Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC Jr, Sorlie P, Stone NJ, Wilson PWF, Jordan HS, Nevo L, Wnek J, Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Smith SC Jr, Tomaselli GF, American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. 2013 ACC\/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation, 2014; 129: S49-S73","DOI":"10.1161\/01.cir.0000437741.48606.98"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimeti\u00e8re P, Jousilahti P, Keil U, Nj\u00f8lstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM, SCORE project group. Estimation of Ten-Year Risk of Fatal Cardiovascular Disease in Europe: The SCORE Project. Eur Heart J, 2003; 24: 987-1003","DOI":"10.1016\/S0195-668X(03)00114-3"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 Risk Prediction Algorithms: New Models to Estimate 10-Year Risk of Cardiovascular Disease in Europe. Eur Heart J, 2021; 42: 2439-2454","DOI":"10.1093\/eurheartj\/ehab309"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) SCORE2-OP working group and ESC Cardiovascular risk collaboration. SCORE2-OP Risk Prediction Algorithms: Estimating Incident Cardiovascular Event Risk in Older Persons in Four Geographical Risk Regions. Eur Heart J, 2021; 42: 2455-2467","DOI":"10.1093\/eurheartj\/ehab312"},{"key":"10","unstructured":"10) Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bansal N, Bello NA, Bress AP, Carter J, Cohen JB, Collins KJ, Commodore-Mensah Y, Davis LL, Egan B, Khan SS, Lloyd-Jones DM, Melnyk BM, Mistry EA, Ogunniyi MO, Schott SL, Smith SC Jr, Talbot AW, Vongpatanasin W, Watson KE, Whelton PK, Williamson JD. 2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2025 [in press]"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Blumenthal RS, Morris PB, Gaudino M, Johnson HM, Anderson TS, Bittner VA, Blankstein R, Brewer LC, Cho L, de Ferranti SD, Gianos E, Gluckman TJ, Gradney KF, Isiadinso I, Lloyd-Jones DM, Marrs JC, Martin SS, McLain KH, Mehta LS, Mora S, Mulugeta WM, Natarajan P, Navar AM, Orringer CE, Polonsky TS, Reynolds HR, Saseen JJ, Shapiro MD, Soffer DE, Tynes SA, Villavaso CD, Virani SS, Wilkins JT. 2026 ACC\/AHA\/AACVPR\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol, 2026. [in press]","DOI":"10.1161\/CIR.0000000000001475"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, Blaha MJ, Carson AP, Chang AR, Ciemins E, Go AS, Gutierrez OM, Hwang SJ, Jassal SK, Kovesdy CP, Lloyd-Jones DM, Shlipak MG, Palaniappan LP, Sperling L, Virani SS, Tuttle K, Neeland IJ, Chow SL, Rangaswami J, Pencina MJ, Ndumele CE, Coresh J, Chronic Kidney Disease Prognosis Consortium, the American Heart Association Cardiovascular-Kidney-Metabolic Science Advisory Group. Development and Validation of the American Heart Association\u2019s PREVENT Equations. Circulation, 2024; 149: 430-449","DOI":"10.1161\/CIRCULATIONAHA.123.067626"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, Coresh J, Mathew RO, Baker-Smith CM, Carnethon MR, Despres JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Singh RR, Elkind MSV, American Heart Association. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory from the American Heart Association. Circulation, 2023; 148: 1606-1635","DOI":"10.1161\/CIR.0000000000001184"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Wilson PW, D\u2019Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation, 1998; 97: 1837-1847","DOI":"10.1161\/01.CIR.97.18.1837"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the Epidemiology of Cardiovascular Disease: A Historical Perspective. Lancet, 2014; 383: 999-1008","DOI":"10.1016\/S0140-6736(13)61752-3"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nomali M, Khalili D, Yaseri M, Mansournia MA, Ayati A, Navid H, Nedjat S. Validity of the Models Predicting 10-Year Risk of Cardiovascular Diseases in Asia: A Systematic Review and Prediction Model Meta-Analysis. PLoS One, 2023; 18: e0292396","DOI":"10.1371\/journal.pone.0292396"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Liu J, Hong Y, D\u2019Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PWF, Kannel WB, Zhao D. Predictive Value for the Chinese Population of the Framingham CHD Risk Assessment Tool Compared with the Chinese Multi-Provincial Cohort Study. JAMA, 2004; 291: 2591-2599","DOI":"10.1001\/jama.291.21.2591"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Stone NJ, Robinson JG, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PWF, American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Reprint: 2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. J Am Pharm Assoc (2003), 2013; 63: e1","DOI":"10.1161\/01.cir.0000437738.63853.7a"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Jung KJ, Jang Y, Oh DJ, Oh BH, Lee SH, Park SW, Seung KB, Kim HK, Yun YD, Choi SH, Sung J, Lee TY, Kim SH, Koh SB, Kim MC, Kim HC, Kimm H, Nam C, Park S, Jee SH. The ACC\/AHA 2013 Pooled Cohort Equations Compared to a Korean Risk Prediction Model for Atherosclerotic Cardiovascular Disease. Atherosclerosis, 2015; 242: 367-375","DOI":"10.1016\/j.atherosclerosis.2015.07.033"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sawano M, Kohsaka S, Okamura T, Inohara T, Sugiyama D, Watanabe M, Nakamura Y, Higashiyama A, Kadota A, Okud N, Murakami Y, Ohkubo T, Fujiyoshi A, Miura K, Okayama A, Ueshima H, Disease NIPFPOONC, its Trends in the Aged (NIPPON DATA 80) Research Group. Validation of the European SCORE Risk Chart in the Healthy Middle-Aged Japanese. Atherosclerosis, 2016; 252: 116-121","DOI":"10.1016\/j.atherosclerosis.2016.07.926"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Yang X, Li J, Hu D, Chen J, Li Y, Huang J, Liu X, Liu F, Cao J, Shen C, Yu L, Lu F, Wu X, Zhao L, Wu X, Gu D. Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China). Circulation, 2016; 134: 1430-1440","DOI":"10.1161\/CIRCULATIONAHA.116.022367"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Okamura T, Tsukamoto K, Arai H, Fujioka Y, Ishigaki Y, Koba S, Ohmura H, Shoji T, Yokote K, Yoshida H, Yoshida M, Deguchi J, Dobashi K, Fujiyoshi A, Hamaguchi H, Hara M, Harada-Shiba M, Hirata T, Iida M, Ikeda Y, Ishibashi S, Kanda H, Kihara S, Kitagawa K, Kodama S, Koseki M, Maezawa Y, Masuda D, Miida T, Miyamoto Y, Nishimura R, Node K, Noguchi M, Ohishi M, Saito I, Sawada S, Sone H, Takemoto M, Wakatsuki A, Yanai H. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022. J Atheroscler Thromb, 2024; 31: 641-853","DOI":"10.5551\/jat.GL2022"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Ohya Y, Arakawa K, Arata N, Arima S, Arima H, Asayama K, Dohi Y, Fukami A, Furuhashi M, Goto K, Goto R, Hatta T, Hirawa N, Hirooka Y, Hisamatsu T, Hoshide S, Ikezumi Y, Inoue S, Ishida M, Ishimitsu T, Iwashima Y, Kabayama M, Kabutoya T, Kai H, Kaneko H, Kanno Y, Katsuya T, Kikuchi T, Koga M, Kudo M, Kuwabara M, Matsumura K, Metoki H, Mito A, Miura SI, Miura K, Miyashita K, Mogi M, Kawakami-Mori F, Morimoto S, Mukai M, Mukoyama M, Munakata M, Nakagawa N, Ohkubo T, Okura T, Rakugi H, Shibata S, Shinohara K, Takami T, Takase H, Takemi Y, Tanaka A, Tomiyama H, Toyoda K, Tsuchihashi T, Ueda S, Yamamoto E, Yamamoto K, Sakima A. The Japanese Society of Hypertension Guidelines for the Management of Elevated Blood Pressure and Hypertension 2025 (JSH2025). Hypertens Res, 2026; 49: 9-235","DOI":"10.1038\/s41440-025-02462-y"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Fujiyoshi A, Kohsaka S, Hata J, Hara M, Kai H, Masuda D, Miyamatsu N, Nishio Y, Ogura M, Sata M, Sekiguchi K, Takeya Y, Tamura K, Wakatsuki A, Yoshida H, Fujioka Y, Fukazawa R, Hamada O, Higashiyama A, Kabayama M, Kanaoka K, Kawaguchi K, Kosaka S, Kunimura A, Miyazaki A, Nii M, Sawano M, Terauchi M, Yagi S, Akasaka T, Minamino T, Miura K, Node K, Japanese Circulation Society Joint Working Group. JCS 2023 Guideline on the Primary Prevention of Coronary Artery Disease. Circ J, 2024; 88: 763-842","DOI":"10.1253\/circj.CJ-23-0285"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Ninomiya T. Japanese Legacy Cohort Studies: The Hisayama Study. Journal of Epidemiology, 2018; 28: 444-451","DOI":"10.2188\/jea.JE20180150"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Honda T, Chen S, Hata J, Yoshida D, Hirakawa Y, Furuta Y, Shibata M, Sakata S, Kitazono T, Ninomiya T. Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study. J Atheroscler Thromb, 2022; 29: 345-361","DOI":"10.5551\/jat.61960"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nakai M, Watanabe M, Kokubo Y, Nishimura K, Higashiyama A, Takegami M, Nakao YM, Okamura T, Miyamoto Y. Development of a Cardiovascular Disease Risk Prediction Model Using the Suita Study, a Population-Based Prospective Cohort Study in Japan. J Atheroscler Thromb, 2020; 27: 1160-1175","DOI":"10.5551\/jat.48843"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Nishimura K, Okamura T, Watanabe M, Nakai M, Takegami M, Higashiyama A, Kokubo Y, Okayama A, Miyamoto Y. Predicting Coronary Heart Disease Using Risk Factor Categories for a Japanese Urban Population, and Comparison with the Framingham Risk Score: The Suita Study. J Atheroscler Thromb, 2014; 21: 784-798","DOI":"10.5551\/jat.19356"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Harada A, Ueshima H, Kinoshita Y, Miura K, Ohkubo T, Asayama K, Ohashi Y, Japan Arteriosclerosis Longitudinal Study Group. Absolute Risk Score for Stroke, Myocardial Infarction, and All Cardiovascular Disease: Japan Arteriosclerosis Longitudinal Study. Hypertens Res, 2019; 42: 567-579","DOI":"10.1038\/s41440-019-0220-z"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Nakai M, Miyamoto Y, Higashiyama A, Murakami Y, Nishimura K, Yatsuya H, Saitoh S, Sakata K, Iso H, Miura K, Ueshima H, Okamura T, EPOCH-JAPAN Research Group. Calibration between the Estimated Probability of the Risk Assessment Chart of Japan Atherosclerosis Society and Actual Mortality Using External Population: Evidence for Cardiovascular Prevention from Observational Cohorts in Japan (EPOCH-JAPAN). J Atheroscler Thromb, 2016; 23: 176-195","DOI":"10.5551\/jat.31286"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Li Y, Yatsuya H, Tanaka S, Iso H, Okayama A, Tsuji I, Sakata K, Miyamoto Y, Ueshima H, Miura K, Murakami Y, Okamura T. Estimation of 10-Year Risk of Death from Coronary Heart Disease, Stroke, and Cardiovascular Disease in a Pooled Analysis of Japanese Cohorts: EPOCH-JAPAN. J Atheroscler Thromb, 2021; 28: 816-825","DOI":"10.5551\/jat.58958"},{"key":"32","unstructured":"32) Framingham Equation Model Overestimates Risk of Ischemic Heart Disease in Korean Men and Women. Korean J Epidemiol, 2006; 28: 162-170"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Jee SH, Park JW, Lee SY, Nam BH, Ryu HG, Kim SY, Kim YN, Lee JK, Choi SM, Yun JE. Stroke Risk Prediction Model: A Risk Profile from the Korean Study. Atherosclerosis, 2008; 197: 318-325","DOI":"10.1016\/j.atherosclerosis.2007.05.014"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Jee SH, Jang Y, Oh DJ, Oh BH, Lee SH, Park SW, Seung KB, Mok Y, Jung KJ, Kimm H, Yun YD, Baek SJ, Lee DC, Choi SH, Kim MJ, Sung J, Cho B, Kim ES, Yu BY, Lee TY, Kim JS, Lee YJ, Oh JK, Kim SH, Park JK, Koh SB, Park SB, Lee SY, Yoo CI, Kim MC, Kim HK, Park JS, Kim HC, Lee GJ, Woodward M. A Coronary Heart Disease Prediction Model: The Korean Heart Study. BMJ Open, 2014; 4: e005025","DOI":"10.1136\/bmjopen-2014-005025"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Cho IJ, Sung JM, Chang HJ, Chung N, Kim HC. Incremental Value of Repeated Risk Factor Measurements for Cardiovascular Disease Prediction in Middle-Aged Korean Adults: Results from the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort). Circ Cardiovasc Qual Outcomes, 2017; 10: e004197","DOI":"10.1161\/CIRCOUTCOMES.117.004197"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Cho IJ, Sung JM, Kim HC, Lee SE, Chae MH, Kavousi M, Rueda-Ochoa OL, Ikram MA, Franco OH, Min JK, Chang HJ. Development and External Validation of a Deep Learning Algorithm for Prognostication of Cardiovascular Outcomes. Korean Circ J, 2020; 50: 72-84","DOI":"10.4070\/kcj.2019.0105"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Choi SH, Lee SM, Kim SH, Park M, Yoon HJ. Prediction of 8-Year Risk of Cardiovascular Diseases in Korean Adult Population. Sci Rep, 2021; 11: 14339","DOI":"10.1038\/s41598-021-93840-2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Park S, Kim YG, Ann SH, Cho YR, Kim SJ, Han S, Park GM. Prediction of the 10-Year Risk of Atherosclerotic Cardiovascular Disease in the Korean Population. Epidemiol Health, 2023; 45: e2023052","DOI":"10.4178\/epih.e2023052"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Committee for the Korean Guidelines for the Management of Dyslipidemia. 2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation). Korean Circ J, 2016; 46: 275-306","DOI":"10.4070\/kcj.2016.46.3.275"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, Coresh J, Baker-Smith CM, Carnethon MR, Despr\u00e9s JP, Ho JE, Joseph JJ, Kernan WN, Khera A, Kosiborod MN, Lekavich CL, Lewis EF, Lo KB, Ozkan B, Palaniappan LP, Patel SS, Pencina MJ, Powell-Wiley TM, Sperling LS, Virani SS, Wright JT, Singh RR, Elkind MSV, Rangaswami J, American Heart Association. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement from the American Heart Association. Circulation, 2023; 148: 1636-1664","DOI":"10.1161\/CIR.0000000000001186"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Ioannidis JPA, Powe NR, Yancy C. Recalibrating the Use of Race in Medical Research. JAMA, 2021; 325: 623-624","DOI":"10.1001\/jama.2021.0003"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, Crews DC, Doria A, Estrella MM, Froissart M, Grams ME, Greene T, Grubb A, Gudnason V, Guti\u00e9rrez OM, Kalil R, Karger AB, Mauer M, Navis G, Nelson RG, Poggio ED, Rodby R, Rossing P, Rule AD, Selvin E, Seegmiller JC, Shlipak MG, Torres VE, Yang W, Ballew SH, Couture SJ, Powe NR, Levey AS, Chronic Kidney Disease Epidemiology Collaboration. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med, 2021; 385: 1737-1749","DOI":"10.1056\/NEJMoa2102953"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Butler DC, Petterson S, Phillips RL, Bazemore AW. Measures of Social Deprivation That Predict Health Care Access and Need within a Rational Area of Primary Care Service Delivery. Health Serv Res, 2013; 48: 539-559","DOI":"10.1111\/j.1475-6773.2012.01449.x"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS. SGLT2 Inhibitors for Primary and Secondary Prevention of Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Cardiovascular Outcome Trials. Lancet, 2019; 393: 31-39","DOI":"10.1016\/S0140-6736(18)32590-X"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GWD, Muntner P, Roderick P, Sairenchi T, Sch\u00f6ttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, \u00c4rnl\u00f6v J, CKD Prognosis Consortium. Estimated Glomerular Filtration Rate and Albuminuria for Prediction of Cardiovascular Outcomes: A Collaborative Meta-Analysis of Individual Participant Data. Lancet Diabetes Endocrinol, 2015; 3: 514-525","DOI":"10.1016\/S2213-8587(15)00040-6"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Vassy JL, Lu B, Ho YL, Galloway A, Raghavan S, Honerlaw J, Tarko L, Russo J, Qazi S, Orkaby AR, Tanukonda V, Djousse L, Gaziano JM, Gagnon DR, Cho K, Wilson PWF. Estimation of Atherosclerotic Cardiovascular Disease Risk among Patients in the Veterans Affairs Health Care System. JAMA Netw Open, 2020; 3: e208236","DOI":"10.1001\/jamanetworkopen.2020.8236"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Mathew RO, Khan SS, Tuttle KR, Ho JE, Abramov D, Bangalore S, Sidhu MS, Ndumele CE, Powell-Wiley TM, Neeland IJ, Coresh J, Elkind MSV, Rangaswami J. Performance of the American Heart Association\u2019s PREVENT Risk Score for Cardiovascular Risk Prediction in a Multiethnic Population. Nat Med, 2025; 31: 2655-2662","DOI":"10.1038\/s41591-025-03789-2"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Zhou H, Zhang Y, Zhou MM, Choi SK, Reynolds K, Harrison TN, Bellows BK, Moran AE, Colantonio LD, Allen NB, Safford MM, An J. Evaluation and Comparison of the PREVENT and Pooled Cohort Equations for 10-Year Atherosclerotic Cardiovascular Risk Prediction. J Am Heart Assoc, 2025; 14: e039454","DOI":"10.1161\/JAHA.124.039454"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Lewis AA, Bacong AM, Palaniappan L, Hernandez-Boussard T. Validation of the American Heart Association Predicting Risk of Cardiovascular Disease Events Equations in Diverse Socioeconomic Groups: The All of Us Cohort. J Am Heart Assoc, 2025; 14: e041549","DOI":"10.1161\/JAHA.125.041549"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Cho SMJ, Levin M, Chen R, Samarakoon R, Judy R, Hartmann K, Postupaka D, Viscosi V, Farber-Eger E, Fahed AC, Honigberg MC, Patel CJ, Hornsby W, Wells QS, Damrauer SM, Do R, Natarajan P. AHA PREVENT Equations and Cardiovascular Disease Risk in Diverse Health Care Populations. J Am Coll Cardiol, 2025; 86: 181-192","DOI":"10.1016\/j.jacc.2025.04.066"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Ambrosio M, Alebna PL, Lee T, Friedman A, Chew NW, Burns C, Duncan P, Hundley WG, Kang L, Mehta A. Performance of PREVENT and Pooled Cohort Equations for Predicting 10-Year ASCVD Risk in the UK Biobank. Am J Prev Cardiol, 2025; 22: 101009","DOI":"10.1016\/j.ajpc.2025.101009"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Roxane DLH, Pedro MV, Julien V. External Validation of the 2023 American Heart Association Predicting Risk of Cardiovascular Disease EVENTs Equations for Atherosclerotic Cardiovascular Disease in Primary Cardiovascular Prevention Setting and Comparison with 2021 Systematic COronary Risk Evaluation and 2013 Pooled Cohort Equations. Eur J Prev Cardiol, 2025; zwaf213. [in press]","DOI":"10.1093\/eurjpc\/zwaf213"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Lee H, Inoue K, Son D, Mori Y, Yang E, Yano Y, Kim HC, Kazi DS, Lloyd-Jones DM, Khan SS. Evaluation of the PREVENT Equations in a Nationwide Cohort of 7.7 Million Korean Adults. J Am Coll Cardiol, 2025; 86: 2395-2398","DOI":"10.1016\/j.jacc.2025.09.1591"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Wang C, Yuan Y, Zheng M, Pan A, Wang M, Zhao M, Li Y, Yao S, Chen S, Wu S, Xue H. Association of Age of Onset of Hypertension with Cardiovascular Diseases and Mortality. J Am Coll Cardiol, 2020; 75: 2921-2930","DOI":"10.1016\/j.jacc.2020.04.038"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Li H, Chen S, Zhang R, Tian X, Wu S, Wang A. Validation and Recalibration of PCE, China-PAR, and PREVENT Models for Estimating ASCVD Risk in China. JACC Asia, 2026; 6: 602-616","DOI":"10.1016\/j.jacasi.2025.12.015"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Murphy BS, Hershey MS, Huang S, Nam Y, Post WS, McClelland RL, DeFilippis AP. PREVENT Risk Score vs the Pooled Cohort Equations in MESA. JACC Adv, 2025; 4: 101825","DOI":"10.1016\/j.jacadv.2025.101825"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Zhang C, Xie B, Wang X, Pan M, Wang J, Ding H, Li T, Lin H, Gu Z. Burden of Heart Failure in Asia, 1990-2019: Findings from the Global Burden of Disease Study 2019. Public Health, 2024; 230: 66-72","DOI":"10.1016\/j.puhe.2024.02.015"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Yang C, Jia Y, Zhang C, Jin Z, Ma Y, Bi X, Tian A. Global, Regional, and National Burdens of Heart Failure in Adolescents and Young Adults Aged 10-24 Years from 1990 to 2021: An Analysis of Data from the Global Burden of Disease Study 2021. EClinicalMedicine, 2025; 79: 102998","DOI":"10.1016\/j.eclinm.2024.102998"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Butler J, Kalogeropoulos A, Georgiopoulou V, Belue R, Rodondi N, Garcia M, Bauer DC, Satterfield S, Smith AL, Vaccarino V, Newman AB, Harris TB, Wilson PWF, Kritchevsky SB, Health ABC Study. Incident Heart Failure Prediction in the Elderly: The Health ABC Heart Failure Score. Circ Heart Fail, 2008; 1: 125-133","DOI":"10.1161\/CIRCHEARTFAILURE.108.768457"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Kalogeropoulos A, Psaty BM, Vasan RS, Georgiopoulou V, Smith AL, Smith NL, Kritchevsky SB, Wilson PWF, Newman AB, Harris TB, Butler J, Cardiovascular Health Study. Validation of the Health ABC Heart Failure Model for Incident Heart Failure Risk Prediction: The Cardiovascular Health Study. Circ Heart Fail, 2010; 3: 495-502","DOI":"10.1161\/CIRCHEARTFAILURE.109.904300"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Agarwal SK, Chambless LE, Ballantyne CM, Astor B, Bertoni AG, Chang PP, Folsom AR, He M, Hoogeveen RC, Ni H, Quibrera PM, Rosamond WD, Russell SD, Shahar E, Heiss G. Prediction of Incident Heart Failure in General Practice: The Atherosclerosis Risk in Communities (ARIC) Study. Circ Heart Fail, 2012; 5: 422-429","DOI":"10.1161\/CIRCHEARTFAILURE.111.964841"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Cunningham JW, Singh P, Reeder C, Lau ES, Khurshid S, Wang X, Ellinor PT, Lubitz SA, Batra P, Ho JE. Natural Language Processing for Adjudication of Heart Failure in the Electronic Health Record. JACC Heart Fail, 2023; 11: 852-854","DOI":"10.1016\/j.jchf.2023.02.012"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Ledwidge M, Gallagher J, Conlon C, Tallon E, O\u2019Connell E, Dawkins I, Watson C, O\u2019Hanlon R, Bermingham M, Patle A, Badabhagni MR, Murtagh G, Voon V, Tilson L, Barry M, McDonald L, Maurer B, McDonald K. Natriuretic Peptide-Based Screening and Collaborative Care for Heart Failure: The STOP-HF Randomized Trial. JAMA, 2013; 310: 66-74","DOI":"10.1001\/jama.2013.7588"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Sweeney C, Ryan F, Ledwidge M, Ryan C, McDonald K, Watson C, Pharithi RB, Gallagher J. Natriuretic Peptide-Guided Treatment for the Prevention of Cardiovascular Events in Patients without Heart Failure. Cochrane Database Syst Rev, 2019; 10: CD013015","DOI":"10.1002\/14651858.CD013015.pub2"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Hirata A, Uchida T. The Specific Health Checkups and Specific Health Guidance Program: A Strategy for the Prevention of Cardiovascular Disease in Japan. J Atheroscler Thromb, 2026; 33: 367-376","DOI":"10.5551\/jat.RV22047"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) National General Health Screening Program in Korea: History, current status, and future direction. Precis Future Med, 2022; 6: 9-31","DOI":"10.23838\/pfm.2021.00135"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Claudel SE, Verma A. Albuminuria in Cardiovascular, Kidney, and Metabolic Disorders: A State-of-the-Art Review. Circulation, 2025; 151: 716-732","DOI":"10.1161\/CIRCULATIONAHA.124.071079"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Konta T, Asahi K, Tamura K, Tanaka F, Fukui A, Nakamura Y, Hirose J, Ohara K, Shijoh Y, Carter M, Meredith K, Harris J, \u00c5kerborg \u00d6, Kashihara N, Yokoo T. The Health-Economic Impact of Urine Albumin-to-Creatinine Ratio Testing for Chronic Kidney Disease in Japanese Non-Diabetic Patients. Clin Exp Nephrol, 2025; 29: 583-595","DOI":"10.1007\/s10157-024-02600-9"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Francis A, Harhay MN, Ong ACM, Tummalapalli SL, Ortiz A, Fogo AB, Fliser D, Roy-Chaudhury P, Fontana M, Nangaku M, Wanner C, Malik C, Hradsky A, Adu D, Bavanandan S, Cusumano A, Sola L, Ulasi I, Jha V, Nephrology ASO, European Renal Association, Nephrology ISO. Chronic Kidney Disease and the Global Public Health Agenda: An International Consensus. Nat Rev Nephrol, 2024; 20: 473-485","DOI":"10.1038\/s41581-024-00820-6"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Nakaya T, Honjo K, Hanibuchi T, Ikeda A, Iso H, Inoue M, Sawada N, Tsugane S, Japan Public Health Center-based Prospective Study Group. Associations of All-Cause Mortality with Census-Based Neighbourhood Deprivation and Population Density in Japan: A Multilevel Survival Analysis. PLoS One, 2014; 9: e97802","DOI":"10.1371\/journal.pone.0097802"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Kataoka A, Fukui K, Sato T, Kikuchi H, Inoue S, Kondo N, Nakaya T, Ito Y. Geographical Socioeconomic Inequalities in Healthy Life Expectancy in Japan, 2010-2014: An Ecological Study. Lancet Reg Health West Pac, 2021; 14: 100204","DOI":"10.1016\/j.lanwpc.2021.100204"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Kim C, Ross JS, Jastreboff AM, Meeker D, Freedman H, Krumholz HM, Lu Y. Uptake of and Disparities in Semaglutide and Tirzepatide Prescribing for Obesity in the US. JAMA, 2025; 333: 2203-2206","DOI":"10.1001\/jama.2025.4735"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Do D, Murugiah K, Sawano M, Cartwright BMG, Rodriguez PJ, Gratzl S, Curtis LH, Jastreboff A, Lu Y, Stucky NL. FDA Cardiovascular Indication Expansion and Dispensing of Semaglutide\/Tirzepatide in CVD Patients with Overweight\/Obesity. JACC Adv, 2026; 5: 102575","DOI":"10.1016\/j.jacadv.2025.102575"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Laranjo L, Car LT, Payne RE, Neves AL, Kidd M, Miranda JJ. Artificial Intelligence in Primary Care: Innovation at a Crossroads. Lancet Prim Care, 2026; 2: 100078","DOI":"10.1016\/j.lanprc.2025.100078"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Dennison Himmelfarb CR, Beckie TM, Allen LA, Commodore-Mensah Y, Davidson PM, Lin G, Lutz B, Spatz ES, American Heart Association Council on Cardiovascular, Nursing S, American Heart Association Council on Cardiovascular, Stroke Nursing; Council on Clinical Cardiology; Council on Quality of Care, Outcomes Research; Council on Hypertension; Council on the Kidney in Cardiovascular Disease; Council on Lifelong Congenital Heart Disease, Heart Health in the Young; Council on Lifestyle, Cardiometabolic Health; Council on Peripheral Vascular Disease; Council on Epidemiology, Prevention; , Stroke Council. Shared Decision-Making and Cardiovascular Health: A Scientific Statement from the American Heart Association. Circulation, 2023; 148: 912-931","DOI":"10.1161\/CIR.0000000000001162"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/10\/33_RV22056\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T05:02:43Z","timestamp":1791003763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/33\/10\/33_RV22056\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":75,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.rv22056","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"RV22056"}}